Insider Selling: Inspire Medical Systems (NYSE:INSP) Insider Sells $57,346.65 in Stock

Posted by George Bondi on Aug 14th, 2026

Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) insider Jason Kelly sold 963 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the transaction, the insider owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Inspire Medical Systems Stock Down 0.1%

Shares of INSP stock opened at $58.24 on Friday. The company has a 50 day moving average price of $49.06 and a 200-day moving average price of $53.44. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03. The firm has a market capitalization of $1.68 billion, a PE ratio of 12.61, a P/E/G ratio of 4.43 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company had revenue of $200.58 million for the quarter, compared to the consensus estimate of $194.72 million. During the same quarter in the prior year, the firm earned $0.45 earnings per share. The firm’s revenue for the quarter was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on INSP shares. Evercore set a $54.00 price objective on Inspire Medical Systems in a research report on Tuesday, August 4th. Freedom Capital raised Inspire Medical Systems to a “strong-buy” rating in a research report on Tuesday, June 30th. KeyCorp reaffirmed a “sector weight” rating on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Stifel Nicolaus set a $75.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Finally, Oppenheimer raised shares of Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 price objective on the stock in a report on Tuesday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $68.00.

Check Out Our Latest Report on Inspire Medical Systems

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in Inspire Medical Systems in the second quarter worth about $211,341,000. Wellington Management Group LLP bought a new position in shares of Inspire Medical Systems during the 4th quarter valued at approximately $203,929,000. Wasatch Advisors LP grew its stake in shares of Inspire Medical Systems by 7.2% during the 2nd quarter. Wasatch Advisors LP now owns 1,634,395 shares of the company’s stock valued at $212,095,000 after acquiring an additional 110,288 shares during the period. Morgan Stanley increased its holdings in Inspire Medical Systems by 179.5% in the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock worth $116,188,000 after acquiring an additional 809,121 shares in the last quarter. Finally, Deerfield Management Company L.P. increased its holdings in Inspire Medical Systems by 648.4% in the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock worth $77,739,000 after acquiring an additional 907,694 shares in the last quarter. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.